Biotech · Private company
Reven Pharmaceuticals, Inc.
Track this companyFree. Adds Reven Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Rejuveinix (RJX) Active ComparatorPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- RJXPhase 1 · Critical Limb IschemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Tolerability and Efficacy of RJX in Patients With COVID-19PHASE1_PHASE2 · UNKNOWN · started Mar 25, 2021ClinicalTrials.gov NCT04708340 · fetched Nov 12, 2026
- A Safety and Tolerability Study of RJX Drug Product in Healthy ParticipantsPHASE1 · COMPLETED · started Aug 24, 2018ClinicalTrials.gov NCT03680105 · fetched Nov 12, 2026